Global Pravastatin Market Report To Share Key Aspects Of The Industry With The Details Of Influence Factors

Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease. The global Pravastatin market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Pravastatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pravastatin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in Pravastatin Market report are Bristol-Myers Squibb, Teva, Sandoz, Apotex, Dr. Reddy’s Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, Aurobindo Pharma, Accord Healthcare, Upsher-Smith Laboratories, Hisun, Jiangxi Boyaseehot Pharmaceutical, Shanghai Shyndec Pharmaceutical, Daiichi Sankyo, North China Pharmaceutical Group and more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc. – INDUSTRIAL JOURNALISM